Important drug interactions exist between cannabidiol oil and commonly prescribed drugs in rheumatology practice - PubMed (original) (raw)

Important drug interactions exist between cannabidiol oil and commonly prescribed drugs in rheumatology practice

Harold Wilson-Morkeh et al. Rheumatology (Oxford). 2020.

No abstract available

PubMed Disclaimer

Similar articles

• The ha(r)sh-drug interactions in rheumatology.
  Williamson LD, Wong P, Manolios N. Williamson LD, et al. Int J Rheum Dis. 2020 Sep;23(9):1258-1260. doi: 10.1111/1756-185X.13939. Epub 2020 Aug 17. Int J Rheum Dis. 2020. PMID: 33405329 No abstract available.
• [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
  Anić B, Cikes N. Anić B, et al. Reumatizam. 2006;53(2):55-8. Reumatizam. 2006. PMID: 17580555 Review. Croatian.
• Geropharmacology for the rheumatologist.
  Percy LA, Fang MA. Percy LA, et al. Rheum Dis Clin North Am. 2000 Aug;26(3):433-54, v-vi. doi: 10.1016/s0889-857x(05)70150-2. Rheum Dis Clin North Am. 2000. PMID: 10989506 Review.
• Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
  Ferraccioli G, De Santis M, Tolusso B. Ferraccioli G, et al. Pharmacogenomics. 2004 Dec;5(8):1107-16. doi: 10.1517/14622416.5.8.1107. Pharmacogenomics. 2004. PMID: 15584877 Review.
• Pharmacogenetics in rheumatology: the prospects and limitations of an emerging field.
  Siva C, Yokoyama WM, McLeod HL. Siva C, et al. Rheumatology (Oxford). 2002 Nov;41(11):1273-9. doi: 10.1093/rheumatology/41.11.1273. Rheumatology (Oxford). 2002. PMID: 12422000 Review.

Cited by

• Drug-Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain.
  Campos MG, China M, Cláudio M, Capinha M, Torres R, Oliveira S, Fortuna A. Campos MG, et al. Pharmaceuticals (Basel). 2024 May 10;17(5):613. doi: 10.3390/ph17050613. Pharmaceuticals (Basel). 2024. PMID: 38794183 Free PMC article. Review.
• Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors.
  Barnes RC, Banjara S, McHann MC, Almodovar S, Henderson-Redmond AN, Morgan DJ, Castro-Piedras I, Guindon J. Barnes RC, et al. J Pharmacol Exp Ther. 2024 Jan 17;388(2):655-669. doi: 10.1124/jpet.123.001855. J Pharmacol Exp Ther. 2024. PMID: 38129125 Free PMC article.
• Cannabinoids in rheumatology: Friend, foe or a bystander?
  Jain N, Moorthy A. Jain N, et al. Musculoskeletal Care. 2022 Jun;20(2):416-428. doi: 10.1002/msc.1636. Epub 2022 Apr 27. Musculoskeletal Care. 2022. PMID: 35476898 Free PMC article. Review.
• Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
  Jain S, Potschka H, Chandra PP, Tripathi M, Vohora D. Jain S, et al. Epilepsy Res. 2021 Aug;174:106675. doi: 10.1016/j.eplepsyres.2021.106675. Epub 2021 May 19. Epilepsy Res. 2021. PMID: 34044300 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information